Global Nasal Decongestant Market

Nasal Decongestant Comprehensive Study by Type (Phenylephrine, Pseudoephedrine, Intranasal Decongestants, Intranasal Corticosteroids, Antihistamines), Application (Sinusitis, Cold, Rhinitis, Nasal Allergies), Form (Nasal Strips, Tablet, Spray, Capsule), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online, Others), End-user (Hospitals, Clinics, Others) Players and Region - Global Market Outlook to 2026

Nasal Decongestant Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Nasal Decongestant Market?

Nasal decongestants are the medicines used to reduce the symptoms of a blocked or stuffy nose caused by infection (such as the common cold, flu) or other breathing illnesses (such as hay fever, allergies, bronchitis). They help to treat congestion associate with upper respiratory infections (URIs), such as the common cold, and flu, allergic rhinitis, or hay fever, rhinosinusitis, and nasal polyps. The factors such as Increased Prevalence of Allergies among People, Increased Awareness about the Effectiveness of Nasal Decongestant and Rise in the Number of Hospitals and Clinics are driving the global Nasal Decongestant market. Also, the Increased Number of Online Pharmacies fueling the market growth. However, Not Very Effective to Reduce Symptoms and Risk of Addiction if Taken for Longer Time are the factors that may restrain the market growth.

The market study is being classified by Type (Phenylephrine, Pseudoephedrine, Intranasal Decongestants, Intranasal Corticosteroids and Antihistamines), by Application (Sinusitis, Cold, Rhinitis and Nasal Allergies) and major geographies with country level break-up.

Abbott Laboratories (United States), GlaxoSmithKline plc (United Kingdom), Cipla Limited (India), Bayer AG (Germany), Adapt Pharma (United States), Cadila Healthcare (India), Nidda Healthcare Holding GmbH (Germany), Procter and Gamble (United States), Transo-Pharm Handels-GmbH (Germany) and Sun Pharmaceutical Industries Ltd. (India) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Taj Pharmaceuticals (India) and McNeil Consumer Healthcare (United States).

The companies are exploring the market by adopting expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to gain a competitive advantage through combined collaborations. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Nasal Decongestant market throughout the predicted period.

Segment Analysis
Analyst at AMA have segmented the market study of Global Nasal Decongestant market by Type, Application and Region.

On the basis of geography, the market of Nasal Decongestant has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • Increased Prevalence of Allergies among People
  • Increased Awareness about Effectiveness of Nasal Decongestant
  • Rise in the Number of Hospitals and Clinics

Market Trend
  • Increased Number of Online Pharmacies
  • Growing Demand for Nasal Decongestant from Asia

Restraints
  • Not Very Effective to Reduce Symptoms
  • Risk of Addiction if Taken for Longer Time

Opportunities
  • Growing Target Patient Population
  • Development of Healthcare Infrastructure in Emerging Economies such as India and China

Challenges
  • Stringent Government Rules and Regulations


Market Leaders and some development strategies
Recently, Abbott has completed the acquisition of St. Jude Medical, Inc., establishing the company as a leader in the medical device arena. It will strengthen the company's leadership while offering innovative products to address more areas of care.
In November 2020, Cipla Health has expanded its product portfolio with Naselin, a nasal decongestant spray. Naselin helps individuals get quick relief from a blocked nose caused by cold and allergy, which often results in disturbed sleep patterns, hampering overall productivity.


Key Target Audience
Nasal Decongestant Manufacturers, Raw Material Suppliers, Distributors, Emerging Companies, Research Professionals and End-users

Report Objectives / Segmentation Covered

By Type
  • Phenylephrine
  • Pseudoephedrine
  • Intranasal Decongestants
  • Intranasal Corticosteroids
  • Antihistamines
By Application
  • Sinusitis
  • Cold
  • Rhinitis
  • Nasal Allergies
By Form
  • Nasal Strips
  • Tablet
  • Spray
  • Capsule

By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online
  • Others

By End-user
  • Hospitals
  • Clinics
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increased Prevalence of Allergies among People
      • 3.2.2. Increased Awareness about Effectiveness of Nasal Decongestant
      • 3.2.3. Rise in the Number of Hospitals and Clinics
    • 3.3. Market Challenges
      • 3.3.1. Stringent Government Rules and Regulations
    • 3.4. Market Trends
      • 3.4.1. Increased Number of Online Pharmacies
      • 3.4.2. Growing Demand for Nasal Decongestant from Asia
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Nasal Decongestant, by Type, Application, Form, Distribution Channel, End-user and Region (value, volume and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Nasal Decongestant (Value)
      • 5.2.1. Global Nasal Decongestant by: Type (Value)
        • 5.2.1.1. Phenylephrine
        • 5.2.1.2. Pseudoephedrine
        • 5.2.1.3. Intranasal Decongestants
        • 5.2.1.4. Intranasal Corticosteroids
        • 5.2.1.5. Antihistamines
      • 5.2.2. Global Nasal Decongestant by: Application (Value)
        • 5.2.2.1. Sinusitis
        • 5.2.2.2. Cold
        • 5.2.2.3. Rhinitis
        • 5.2.2.4. Nasal Allergies
      • 5.2.3. Global Nasal Decongestant by: Form (Value)
        • 5.2.3.1. Nasal Strips
        • 5.2.3.2. Tablet
        • 5.2.3.3. Spray
        • 5.2.3.4. Capsule
      • 5.2.4. Global Nasal Decongestant by: Distribution Channel (Value)
        • 5.2.4.1. Hospital Pharmacies
        • 5.2.4.2. Retail Pharmacies
        • 5.2.4.3. Online
        • 5.2.4.4. Others
      • 5.2.5. Global Nasal Decongestant by: End-user (Value)
        • 5.2.5.1. Hospitals
        • 5.2.5.2. Clinics
        • 5.2.5.3. Others
      • 5.2.6. Global Nasal Decongestant Region
        • 5.2.6.1. South America
          • 5.2.6.1.1. Brazil
          • 5.2.6.1.2. Argentina
          • 5.2.6.1.3. Rest of South America
        • 5.2.6.2. Asia Pacific
          • 5.2.6.2.1. China
          • 5.2.6.2.2. Japan
          • 5.2.6.2.3. India
          • 5.2.6.2.4. South Korea
          • 5.2.6.2.5. Taiwan
          • 5.2.6.2.6. Australia
          • 5.2.6.2.7. Rest of Asia-Pacific
        • 5.2.6.3. Europe
          • 5.2.6.3.1. Germany
          • 5.2.6.3.2. France
          • 5.2.6.3.3. Italy
          • 5.2.6.3.4. United Kingdom
          • 5.2.6.3.5. Netherlands
          • 5.2.6.3.6. Rest of Europe
        • 5.2.6.4. MEA
          • 5.2.6.4.1. Middle East
          • 5.2.6.4.2. Africa
        • 5.2.6.5. North America
          • 5.2.6.5.1. United States
          • 5.2.6.5.2. Canada
          • 5.2.6.5.3. Mexico
    • 5.3. Global Nasal Decongestant (Volume)
      • 5.3.1. Global Nasal Decongestant by: Type (Volume)
        • 5.3.1.1. Phenylephrine
        • 5.3.1.2. Pseudoephedrine
        • 5.3.1.3. Intranasal Decongestants
        • 5.3.1.4. Intranasal Corticosteroids
        • 5.3.1.5. Antihistamines
      • 5.3.2. Global Nasal Decongestant by: Application (Volume)
        • 5.3.2.1. Sinusitis
        • 5.3.2.2. Cold
        • 5.3.2.3. Rhinitis
        • 5.3.2.4. Nasal Allergies
      • 5.3.3. Global Nasal Decongestant by: Form (Volume)
        • 5.3.3.1. Nasal Strips
        • 5.3.3.2. Tablet
        • 5.3.3.3. Spray
        • 5.3.3.4. Capsule
      • 5.3.4. Global Nasal Decongestant by: Distribution Channel (Volume)
        • 5.3.4.1. Hospital Pharmacies
        • 5.3.4.2. Retail Pharmacies
        • 5.3.4.3. Online
        • 5.3.4.4. Others
      • 5.3.5. Global Nasal Decongestant by: End-user (Volume)
        • 5.3.5.1. Hospitals
        • 5.3.5.2. Clinics
        • 5.3.5.3. Others
      • 5.3.6. Global Nasal Decongestant Region
        • 5.3.6.1. South America
          • 5.3.6.1.1. Brazil
          • 5.3.6.1.2. Argentina
          • 5.3.6.1.3. Rest of South America
        • 5.3.6.2. Asia Pacific
          • 5.3.6.2.1. China
          • 5.3.6.2.2. Japan
          • 5.3.6.2.3. India
          • 5.3.6.2.4. South Korea
          • 5.3.6.2.5. Taiwan
          • 5.3.6.2.6. Australia
          • 5.3.6.2.7. Rest of Asia-Pacific
        • 5.3.6.3. Europe
          • 5.3.6.3.1. Germany
          • 5.3.6.3.2. France
          • 5.3.6.3.3. Italy
          • 5.3.6.3.4. United Kingdom
          • 5.3.6.3.5. Netherlands
          • 5.3.6.3.6. Rest of Europe
        • 5.3.6.4. MEA
          • 5.3.6.4.1. Middle East
          • 5.3.6.4.2. Africa
        • 5.3.6.5. North America
          • 5.3.6.5.1. United States
          • 5.3.6.5.2. Canada
          • 5.3.6.5.3. Mexico
    • 5.4. Global Nasal Decongestant (Price)
      • 5.4.1. Global Nasal Decongestant by: Type (Price)
  • 6. Nasal Decongestant: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Abbott Laboratories (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. GlaxoSmithKline plc (United Kingdom)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Cipla Limited (India)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Bayer AG (Germany)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Adapt Pharma (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Cadila Healthcare (India)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Nidda Healthcare Holding GmbH (Germany)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Procter and Gamble (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Transo-Pharm Handels-GmbH (Germany)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Sun Pharmaceutical Industries Ltd. (India)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Nasal Decongestant Sale, by Type, Application, Form, Distribution Channel, End-user and Region (value, volume and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Nasal Decongestant (Value)
      • 7.2.1. Global Nasal Decongestant by: Type (Value)
        • 7.2.1.1. Phenylephrine
        • 7.2.1.2. Pseudoephedrine
        • 7.2.1.3. Intranasal Decongestants
        • 7.2.1.4. Intranasal Corticosteroids
        • 7.2.1.5. Antihistamines
      • 7.2.2. Global Nasal Decongestant by: Application (Value)
        • 7.2.2.1. Sinusitis
        • 7.2.2.2. Cold
        • 7.2.2.3. Rhinitis
        • 7.2.2.4. Nasal Allergies
      • 7.2.3. Global Nasal Decongestant by: Form (Value)
        • 7.2.3.1. Nasal Strips
        • 7.2.3.2. Tablet
        • 7.2.3.3. Spray
        • 7.2.3.4. Capsule
      • 7.2.4. Global Nasal Decongestant by: Distribution Channel (Value)
        • 7.2.4.1. Hospital Pharmacies
        • 7.2.4.2. Retail Pharmacies
        • 7.2.4.3. Online
        • 7.2.4.4. Others
      • 7.2.5. Global Nasal Decongestant by: End-user (Value)
        • 7.2.5.1. Hospitals
        • 7.2.5.2. Clinics
        • 7.2.5.3. Others
      • 7.2.6. Global Nasal Decongestant Region
        • 7.2.6.1. South America
          • 7.2.6.1.1. Brazil
          • 7.2.6.1.2. Argentina
          • 7.2.6.1.3. Rest of South America
        • 7.2.6.2. Asia Pacific
          • 7.2.6.2.1. China
          • 7.2.6.2.2. Japan
          • 7.2.6.2.3. India
          • 7.2.6.2.4. South Korea
          • 7.2.6.2.5. Taiwan
          • 7.2.6.2.6. Australia
          • 7.2.6.2.7. Rest of Asia-Pacific
        • 7.2.6.3. Europe
          • 7.2.6.3.1. Germany
          • 7.2.6.3.2. France
          • 7.2.6.3.3. Italy
          • 7.2.6.3.4. United Kingdom
          • 7.2.6.3.5. Netherlands
          • 7.2.6.3.6. Rest of Europe
        • 7.2.6.4. MEA
          • 7.2.6.4.1. Middle East
          • 7.2.6.4.2. Africa
        • 7.2.6.5. North America
          • 7.2.6.5.1. United States
          • 7.2.6.5.2. Canada
          • 7.2.6.5.3. Mexico
    • 7.3. Global Nasal Decongestant (Volume)
      • 7.3.1. Global Nasal Decongestant by: Type (Volume)
        • 7.3.1.1. Phenylephrine
        • 7.3.1.2. Pseudoephedrine
        • 7.3.1.3. Intranasal Decongestants
        • 7.3.1.4. Intranasal Corticosteroids
        • 7.3.1.5. Antihistamines
      • 7.3.2. Global Nasal Decongestant by: Application (Volume)
        • 7.3.2.1. Sinusitis
        • 7.3.2.2. Cold
        • 7.3.2.3. Rhinitis
        • 7.3.2.4. Nasal Allergies
      • 7.3.3. Global Nasal Decongestant by: Form (Volume)
        • 7.3.3.1. Nasal Strips
        • 7.3.3.2. Tablet
        • 7.3.3.3. Spray
        • 7.3.3.4. Capsule
      • 7.3.4. Global Nasal Decongestant by: Distribution Channel (Volume)
        • 7.3.4.1. Hospital Pharmacies
        • 7.3.4.2. Retail Pharmacies
        • 7.3.4.3. Online
        • 7.3.4.4. Others
      • 7.3.5. Global Nasal Decongestant by: End-user (Volume)
        • 7.3.5.1. Hospitals
        • 7.3.5.2. Clinics
        • 7.3.5.3. Others
      • 7.3.6. Global Nasal Decongestant Region
        • 7.3.6.1. South America
          • 7.3.6.1.1. Brazil
          • 7.3.6.1.2. Argentina
          • 7.3.6.1.3. Rest of South America
        • 7.3.6.2. Asia Pacific
          • 7.3.6.2.1. China
          • 7.3.6.2.2. Japan
          • 7.3.6.2.3. India
          • 7.3.6.2.4. South Korea
          • 7.3.6.2.5. Taiwan
          • 7.3.6.2.6. Australia
          • 7.3.6.2.7. Rest of Asia-Pacific
        • 7.3.6.3. Europe
          • 7.3.6.3.1. Germany
          • 7.3.6.3.2. France
          • 7.3.6.3.3. Italy
          • 7.3.6.3.4. United Kingdom
          • 7.3.6.3.5. Netherlands
          • 7.3.6.3.6. Rest of Europe
        • 7.3.6.4. MEA
          • 7.3.6.4.1. Middle East
          • 7.3.6.4.2. Africa
        • 7.3.6.5. North America
          • 7.3.6.5.1. United States
          • 7.3.6.5.2. Canada
          • 7.3.6.5.3. Mexico
    • 7.4. Global Nasal Decongestant (Price)
      • 7.4.1. Global Nasal Decongestant by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Nasal Decongestant: by Type(USD Million)
  • Table 2. Nasal Decongestant Phenylephrine , by Region USD Million (2015-2020)
  • Table 3. Nasal Decongestant Pseudoephedrine , by Region USD Million (2015-2020)
  • Table 4. Nasal Decongestant Intranasal Decongestants , by Region USD Million (2015-2020)
  • Table 5. Nasal Decongestant Intranasal Corticosteroids , by Region USD Million (2015-2020)
  • Table 6. Nasal Decongestant Antihistamines , by Region USD Million (2015-2020)
  • Table 7. Nasal Decongestant: by Application(USD Million)
  • Table 8. Nasal Decongestant Sinusitis , by Region USD Million (2015-2020)
  • Table 9. Nasal Decongestant Cold , by Region USD Million (2015-2020)
  • Table 10. Nasal Decongestant Rhinitis , by Region USD Million (2015-2020)
  • Table 11. Nasal Decongestant Nasal Allergies , by Region USD Million (2015-2020)
  • Table 12. Nasal Decongestant: by Form(USD Million)
  • Table 13. Nasal Decongestant Nasal Strips , by Region USD Million (2015-2020)
  • Table 14. Nasal Decongestant Tablet , by Region USD Million (2015-2020)
  • Table 15. Nasal Decongestant Spray , by Region USD Million (2015-2020)
  • Table 16. Nasal Decongestant Capsule , by Region USD Million (2015-2020)
  • Table 17. Nasal Decongestant: by Distribution Channel(USD Million)
  • Table 18. Nasal Decongestant Hospital Pharmacies , by Region USD Million (2015-2020)
  • Table 19. Nasal Decongestant Retail Pharmacies , by Region USD Million (2015-2020)
  • Table 20. Nasal Decongestant Online , by Region USD Million (2015-2020)
  • Table 21. Nasal Decongestant Others , by Region USD Million (2015-2020)
  • Table 22. Nasal Decongestant: by End-user(USD Million)
  • Table 23. Nasal Decongestant Hospitals , by Region USD Million (2015-2020)
  • Table 24. Nasal Decongestant Clinics , by Region USD Million (2015-2020)
  • Table 25. Nasal Decongestant Others , by Region USD Million (2015-2020)
  • Table 26. South America Nasal Decongestant, by Country USD Million (2015-2020)
  • Table 27. South America Nasal Decongestant, by Type USD Million (2015-2020)
  • Table 28. South America Nasal Decongestant, by Application USD Million (2015-2020)
  • Table 29. South America Nasal Decongestant, by Form USD Million (2015-2020)
  • Table 30. South America Nasal Decongestant, by Distribution Channel USD Million (2015-2020)
  • Table 31. South America Nasal Decongestant, by End-user USD Million (2015-2020)
  • Table 32. Brazil Nasal Decongestant, by Type USD Million (2015-2020)
  • Table 33. Brazil Nasal Decongestant, by Application USD Million (2015-2020)
  • Table 34. Brazil Nasal Decongestant, by Form USD Million (2015-2020)
  • Table 35. Brazil Nasal Decongestant, by Distribution Channel USD Million (2015-2020)
  • Table 36. Brazil Nasal Decongestant, by End-user USD Million (2015-2020)
  • Table 37. Argentina Nasal Decongestant, by Type USD Million (2015-2020)
  • Table 38. Argentina Nasal Decongestant, by Application USD Million (2015-2020)
  • Table 39. Argentina Nasal Decongestant, by Form USD Million (2015-2020)
  • Table 40. Argentina Nasal Decongestant, by Distribution Channel USD Million (2015-2020)
  • Table 41. Argentina Nasal Decongestant, by End-user USD Million (2015-2020)
  • Table 42. Rest of South America Nasal Decongestant, by Type USD Million (2015-2020)
  • Table 43. Rest of South America Nasal Decongestant, by Application USD Million (2015-2020)
  • Table 44. Rest of South America Nasal Decongestant, by Form USD Million (2015-2020)
  • Table 45. Rest of South America Nasal Decongestant, by Distribution Channel USD Million (2015-2020)
  • Table 46. Rest of South America Nasal Decongestant, by End-user USD Million (2015-2020)
  • Table 47. Asia Pacific Nasal Decongestant, by Country USD Million (2015-2020)
  • Table 48. Asia Pacific Nasal Decongestant, by Type USD Million (2015-2020)
  • Table 49. Asia Pacific Nasal Decongestant, by Application USD Million (2015-2020)
  • Table 50. Asia Pacific Nasal Decongestant, by Form USD Million (2015-2020)
  • Table 51. Asia Pacific Nasal Decongestant, by Distribution Channel USD Million (2015-2020)
  • Table 52. Asia Pacific Nasal Decongestant, by End-user USD Million (2015-2020)
  • Table 53. China Nasal Decongestant, by Type USD Million (2015-2020)
  • Table 54. China Nasal Decongestant, by Application USD Million (2015-2020)
  • Table 55. China Nasal Decongestant, by Form USD Million (2015-2020)
  • Table 56. China Nasal Decongestant, by Distribution Channel USD Million (2015-2020)
  • Table 57. China Nasal Decongestant, by End-user USD Million (2015-2020)
  • Table 58. Japan Nasal Decongestant, by Type USD Million (2015-2020)
  • Table 59. Japan Nasal Decongestant, by Application USD Million (2015-2020)
  • Table 60. Japan Nasal Decongestant, by Form USD Million (2015-2020)
  • Table 61. Japan Nasal Decongestant, by Distribution Channel USD Million (2015-2020)
  • Table 62. Japan Nasal Decongestant, by End-user USD Million (2015-2020)
  • Table 63. India Nasal Decongestant, by Type USD Million (2015-2020)
  • Table 64. India Nasal Decongestant, by Application USD Million (2015-2020)
  • Table 65. India Nasal Decongestant, by Form USD Million (2015-2020)
  • Table 66. India Nasal Decongestant, by Distribution Channel USD Million (2015-2020)
  • Table 67. India Nasal Decongestant, by End-user USD Million (2015-2020)
  • Table 68. South Korea Nasal Decongestant, by Type USD Million (2015-2020)
  • Table 69. South Korea Nasal Decongestant, by Application USD Million (2015-2020)
  • Table 70. South Korea Nasal Decongestant, by Form USD Million (2015-2020)
  • Table 71. South Korea Nasal Decongestant, by Distribution Channel USD Million (2015-2020)
  • Table 72. South Korea Nasal Decongestant, by End-user USD Million (2015-2020)
  • Table 73. Taiwan Nasal Decongestant, by Type USD Million (2015-2020)
  • Table 74. Taiwan Nasal Decongestant, by Application USD Million (2015-2020)
  • Table 75. Taiwan Nasal Decongestant, by Form USD Million (2015-2020)
  • Table 76. Taiwan Nasal Decongestant, by Distribution Channel USD Million (2015-2020)
  • Table 77. Taiwan Nasal Decongestant, by End-user USD Million (2015-2020)
  • Table 78. Australia Nasal Decongestant, by Type USD Million (2015-2020)
  • Table 79. Australia Nasal Decongestant, by Application USD Million (2015-2020)
  • Table 80. Australia Nasal Decongestant, by Form USD Million (2015-2020)
  • Table 81. Australia Nasal Decongestant, by Distribution Channel USD Million (2015-2020)
  • Table 82. Australia Nasal Decongestant, by End-user USD Million (2015-2020)
  • Table 83. Rest of Asia-Pacific Nasal Decongestant, by Type USD Million (2015-2020)
  • Table 84. Rest of Asia-Pacific Nasal Decongestant, by Application USD Million (2015-2020)
  • Table 85. Rest of Asia-Pacific Nasal Decongestant, by Form USD Million (2015-2020)
  • Table 86. Rest of Asia-Pacific Nasal Decongestant, by Distribution Channel USD Million (2015-2020)
  • Table 87. Rest of Asia-Pacific Nasal Decongestant, by End-user USD Million (2015-2020)
  • Table 88. Europe Nasal Decongestant, by Country USD Million (2015-2020)
  • Table 89. Europe Nasal Decongestant, by Type USD Million (2015-2020)
  • Table 90. Europe Nasal Decongestant, by Application USD Million (2015-2020)
  • Table 91. Europe Nasal Decongestant, by Form USD Million (2015-2020)
  • Table 92. Europe Nasal Decongestant, by Distribution Channel USD Million (2015-2020)
  • Table 93. Europe Nasal Decongestant, by End-user USD Million (2015-2020)
  • Table 94. Germany Nasal Decongestant, by Type USD Million (2015-2020)
  • Table 95. Germany Nasal Decongestant, by Application USD Million (2015-2020)
  • Table 96. Germany Nasal Decongestant, by Form USD Million (2015-2020)
  • Table 97. Germany Nasal Decongestant, by Distribution Channel USD Million (2015-2020)
  • Table 98. Germany Nasal Decongestant, by End-user USD Million (2015-2020)
  • Table 99. France Nasal Decongestant, by Type USD Million (2015-2020)
  • Table 100. France Nasal Decongestant, by Application USD Million (2015-2020)
  • Table 101. France Nasal Decongestant, by Form USD Million (2015-2020)
  • Table 102. France Nasal Decongestant, by Distribution Channel USD Million (2015-2020)
  • Table 103. France Nasal Decongestant, by End-user USD Million (2015-2020)
  • Table 104. Italy Nasal Decongestant, by Type USD Million (2015-2020)
  • Table 105. Italy Nasal Decongestant, by Application USD Million (2015-2020)
  • Table 106. Italy Nasal Decongestant, by Form USD Million (2015-2020)
  • Table 107. Italy Nasal Decongestant, by Distribution Channel USD Million (2015-2020)
  • Table 108. Italy Nasal Decongestant, by End-user USD Million (2015-2020)
  • Table 109. United Kingdom Nasal Decongestant, by Type USD Million (2015-2020)
  • Table 110. United Kingdom Nasal Decongestant, by Application USD Million (2015-2020)
  • Table 111. United Kingdom Nasal Decongestant, by Form USD Million (2015-2020)
  • Table 112. United Kingdom Nasal Decongestant, by Distribution Channel USD Million (2015-2020)
  • Table 113. United Kingdom Nasal Decongestant, by End-user USD Million (2015-2020)
  • Table 114. Netherlands Nasal Decongestant, by Type USD Million (2015-2020)
  • Table 115. Netherlands Nasal Decongestant, by Application USD Million (2015-2020)
  • Table 116. Netherlands Nasal Decongestant, by Form USD Million (2015-2020)
  • Table 117. Netherlands Nasal Decongestant, by Distribution Channel USD Million (2015-2020)
  • Table 118. Netherlands Nasal Decongestant, by End-user USD Million (2015-2020)
  • Table 119. Rest of Europe Nasal Decongestant, by Type USD Million (2015-2020)
  • Table 120. Rest of Europe Nasal Decongestant, by Application USD Million (2015-2020)
  • Table 121. Rest of Europe Nasal Decongestant, by Form USD Million (2015-2020)
  • Table 122. Rest of Europe Nasal Decongestant, by Distribution Channel USD Million (2015-2020)
  • Table 123. Rest of Europe Nasal Decongestant, by End-user USD Million (2015-2020)
  • Table 124. MEA Nasal Decongestant, by Country USD Million (2015-2020)
  • Table 125. MEA Nasal Decongestant, by Type USD Million (2015-2020)
  • Table 126. MEA Nasal Decongestant, by Application USD Million (2015-2020)
  • Table 127. MEA Nasal Decongestant, by Form USD Million (2015-2020)
  • Table 128. MEA Nasal Decongestant, by Distribution Channel USD Million (2015-2020)
  • Table 129. MEA Nasal Decongestant, by End-user USD Million (2015-2020)
  • Table 130. Middle East Nasal Decongestant, by Type USD Million (2015-2020)
  • Table 131. Middle East Nasal Decongestant, by Application USD Million (2015-2020)
  • Table 132. Middle East Nasal Decongestant, by Form USD Million (2015-2020)
  • Table 133. Middle East Nasal Decongestant, by Distribution Channel USD Million (2015-2020)
  • Table 134. Middle East Nasal Decongestant, by End-user USD Million (2015-2020)
  • Table 135. Africa Nasal Decongestant, by Type USD Million (2015-2020)
  • Table 136. Africa Nasal Decongestant, by Application USD Million (2015-2020)
  • Table 137. Africa Nasal Decongestant, by Form USD Million (2015-2020)
  • Table 138. Africa Nasal Decongestant, by Distribution Channel USD Million (2015-2020)
  • Table 139. Africa Nasal Decongestant, by End-user USD Million (2015-2020)
  • Table 140. North America Nasal Decongestant, by Country USD Million (2015-2020)
  • Table 141. North America Nasal Decongestant, by Type USD Million (2015-2020)
  • Table 142. North America Nasal Decongestant, by Application USD Million (2015-2020)
  • Table 143. North America Nasal Decongestant, by Form USD Million (2015-2020)
  • Table 144. North America Nasal Decongestant, by Distribution Channel USD Million (2015-2020)
  • Table 145. North America Nasal Decongestant, by End-user USD Million (2015-2020)
  • Table 146. United States Nasal Decongestant, by Type USD Million (2015-2020)
  • Table 147. United States Nasal Decongestant, by Application USD Million (2015-2020)
  • Table 148. United States Nasal Decongestant, by Form USD Million (2015-2020)
  • Table 149. United States Nasal Decongestant, by Distribution Channel USD Million (2015-2020)
  • Table 150. United States Nasal Decongestant, by End-user USD Million (2015-2020)
  • Table 151. Canada Nasal Decongestant, by Type USD Million (2015-2020)
  • Table 152. Canada Nasal Decongestant, by Application USD Million (2015-2020)
  • Table 153. Canada Nasal Decongestant, by Form USD Million (2015-2020)
  • Table 154. Canada Nasal Decongestant, by Distribution Channel USD Million (2015-2020)
  • Table 155. Canada Nasal Decongestant, by End-user USD Million (2015-2020)
  • Table 156. Mexico Nasal Decongestant, by Type USD Million (2015-2020)
  • Table 157. Mexico Nasal Decongestant, by Application USD Million (2015-2020)
  • Table 158. Mexico Nasal Decongestant, by Form USD Million (2015-2020)
  • Table 159. Mexico Nasal Decongestant, by Distribution Channel USD Million (2015-2020)
  • Table 160. Mexico Nasal Decongestant, by End-user USD Million (2015-2020)
  • Table 161. Nasal Decongestant Sales: by Type(K Units)
  • Table 162. Nasal Decongestant Sales Phenylephrine , by Region K Units (2015-2020)
  • Table 163. Nasal Decongestant Sales Pseudoephedrine , by Region K Units (2015-2020)
  • Table 164. Nasal Decongestant Sales Intranasal Decongestants , by Region K Units (2015-2020)
  • Table 165. Nasal Decongestant Sales Intranasal Corticosteroids , by Region K Units (2015-2020)
  • Table 166. Nasal Decongestant Sales Antihistamines , by Region K Units (2015-2020)
  • Table 167. Nasal Decongestant Sales: by Application(K Units)
  • Table 168. Nasal Decongestant Sales Sinusitis , by Region K Units (2015-2020)
  • Table 169. Nasal Decongestant Sales Cold , by Region K Units (2015-2020)
  • Table 170. Nasal Decongestant Sales Rhinitis , by Region K Units (2015-2020)
  • Table 171. Nasal Decongestant Sales Nasal Allergies , by Region K Units (2015-2020)
  • Table 172. Nasal Decongestant Sales: by Form(K Units)
  • Table 173. Nasal Decongestant Sales Nasal Strips , by Region K Units (2015-2020)
  • Table 174. Nasal Decongestant Sales Tablet , by Region K Units (2015-2020)
  • Table 175. Nasal Decongestant Sales Spray , by Region K Units (2015-2020)
  • Table 176. Nasal Decongestant Sales Capsule , by Region K Units (2015-2020)
  • Table 177. Nasal Decongestant Sales: by Distribution Channel(K Units)
  • Table 178. Nasal Decongestant Sales Hospital Pharmacies , by Region K Units (2015-2020)
  • Table 179. Nasal Decongestant Sales Retail Pharmacies , by Region K Units (2015-2020)
  • Table 180. Nasal Decongestant Sales Online , by Region K Units (2015-2020)
  • Table 181. Nasal Decongestant Sales Others , by Region K Units (2015-2020)
  • Table 182. Nasal Decongestant Sales: by End-user(K Units)
  • Table 183. Nasal Decongestant Sales Hospitals , by Region K Units (2015-2020)
  • Table 184. Nasal Decongestant Sales Clinics , by Region K Units (2015-2020)
  • Table 185. Nasal Decongestant Sales Others , by Region K Units (2015-2020)
  • Table 186. South America Nasal Decongestant Sales, by Country K Units (2015-2020)
  • Table 187. South America Nasal Decongestant Sales, by Type K Units (2015-2020)
  • Table 188. South America Nasal Decongestant Sales, by Application K Units (2015-2020)
  • Table 189. South America Nasal Decongestant Sales, by Form K Units (2015-2020)
  • Table 190. South America Nasal Decongestant Sales, by Distribution Channel K Units (2015-2020)
  • Table 191. South America Nasal Decongestant Sales, by End-user K Units (2015-2020)
  • Table 192. Brazil Nasal Decongestant Sales, by Type K Units (2015-2020)
  • Table 193. Brazil Nasal Decongestant Sales, by Application K Units (2015-2020)
  • Table 194. Brazil Nasal Decongestant Sales, by Form K Units (2015-2020)
  • Table 195. Brazil Nasal Decongestant Sales, by Distribution Channel K Units (2015-2020)
  • Table 196. Brazil Nasal Decongestant Sales, by End-user K Units (2015-2020)
  • Table 197. Argentina Nasal Decongestant Sales, by Type K Units (2015-2020)
  • Table 198. Argentina Nasal Decongestant Sales, by Application K Units (2015-2020)
  • Table 199. Argentina Nasal Decongestant Sales, by Form K Units (2015-2020)
  • Table 200. Argentina Nasal Decongestant Sales, by Distribution Channel K Units (2015-2020)
  • Table 201. Argentina Nasal Decongestant Sales, by End-user K Units (2015-2020)
  • Table 202. Rest of South America Nasal Decongestant Sales, by Type K Units (2015-2020)
  • Table 203. Rest of South America Nasal Decongestant Sales, by Application K Units (2015-2020)
  • Table 204. Rest of South America Nasal Decongestant Sales, by Form K Units (2015-2020)
  • Table 205. Rest of South America Nasal Decongestant Sales, by Distribution Channel K Units (2015-2020)
  • Table 206. Rest of South America Nasal Decongestant Sales, by End-user K Units (2015-2020)
  • Table 207. Asia Pacific Nasal Decongestant Sales, by Country K Units (2015-2020)
  • Table 208. Asia Pacific Nasal Decongestant Sales, by Type K Units (2015-2020)
  • Table 209. Asia Pacific Nasal Decongestant Sales, by Application K Units (2015-2020)
  • Table 210. Asia Pacific Nasal Decongestant Sales, by Form K Units (2015-2020)
  • Table 211. Asia Pacific Nasal Decongestant Sales, by Distribution Channel K Units (2015-2020)
  • Table 212. Asia Pacific Nasal Decongestant Sales, by End-user K Units (2015-2020)
  • Table 213. China Nasal Decongestant Sales, by Type K Units (2015-2020)
  • Table 214. China Nasal Decongestant Sales, by Application K Units (2015-2020)
  • Table 215. China Nasal Decongestant Sales, by Form K Units (2015-2020)
  • Table 216. China Nasal Decongestant Sales, by Distribution Channel K Units (2015-2020)
  • Table 217. China Nasal Decongestant Sales, by End-user K Units (2015-2020)
  • Table 218. Japan Nasal Decongestant Sales, by Type K Units (2015-2020)
  • Table 219. Japan Nasal Decongestant Sales, by Application K Units (2015-2020)
  • Table 220. Japan Nasal Decongestant Sales, by Form K Units (2015-2020)
  • Table 221. Japan Nasal Decongestant Sales, by Distribution Channel K Units (2015-2020)
  • Table 222. Japan Nasal Decongestant Sales, by End-user K Units (2015-2020)
  • Table 223. India Nasal Decongestant Sales, by Type K Units (2015-2020)
  • Table 224. India Nasal Decongestant Sales, by Application K Units (2015-2020)
  • Table 225. India Nasal Decongestant Sales, by Form K Units (2015-2020)
  • Table 226. India Nasal Decongestant Sales, by Distribution Channel K Units (2015-2020)
  • Table 227. India Nasal Decongestant Sales, by End-user K Units (2015-2020)
  • Table 228. South Korea Nasal Decongestant Sales, by Type K Units (2015-2020)
  • Table 229. South Korea Nasal Decongestant Sales, by Application K Units (2015-2020)
  • Table 230. South Korea Nasal Decongestant Sales, by Form K Units (2015-2020)
  • Table 231. South Korea Nasal Decongestant Sales, by Distribution Channel K Units (2015-2020)
  • Table 232. South Korea Nasal Decongestant Sales, by End-user K Units (2015-2020)
  • Table 233. Taiwan Nasal Decongestant Sales, by Type K Units (2015-2020)
  • Table 234. Taiwan Nasal Decongestant Sales, by Application K Units (2015-2020)
  • Table 235. Taiwan Nasal Decongestant Sales, by Form K Units (2015-2020)
  • Table 236. Taiwan Nasal Decongestant Sales, by Distribution Channel K Units (2015-2020)
  • Table 237. Taiwan Nasal Decongestant Sales, by End-user K Units (2015-2020)
  • Table 238. Australia Nasal Decongestant Sales, by Type K Units (2015-2020)
  • Table 239. Australia Nasal Decongestant Sales, by Application K Units (2015-2020)
  • Table 240. Australia Nasal Decongestant Sales, by Form K Units (2015-2020)
  • Table 241. Australia Nasal Decongestant Sales, by Distribution Channel K Units (2015-2020)
  • Table 242. Australia Nasal Decongestant Sales, by End-user K Units (2015-2020)
  • Table 243. Rest of Asia-Pacific Nasal Decongestant Sales, by Type K Units (2015-2020)
  • Table 244. Rest of Asia-Pacific Nasal Decongestant Sales, by Application K Units (2015-2020)
  • Table 245. Rest of Asia-Pacific Nasal Decongestant Sales, by Form K Units (2015-2020)
  • Table 246. Rest of Asia-Pacific Nasal Decongestant Sales, by Distribution Channel K Units (2015-2020)
  • Table 247. Rest of Asia-Pacific Nasal Decongestant Sales, by End-user K Units (2015-2020)
  • Table 248. Europe Nasal Decongestant Sales, by Country K Units (2015-2020)
  • Table 249. Europe Nasal Decongestant Sales, by Type K Units (2015-2020)
  • Table 250. Europe Nasal Decongestant Sales, by Application K Units (2015-2020)
  • Table 251. Europe Nasal Decongestant Sales, by Form K Units (2015-2020)
  • Table 252. Europe Nasal Decongestant Sales, by Distribution Channel K Units (2015-2020)
  • Table 253. Europe Nasal Decongestant Sales, by End-user K Units (2015-2020)
  • Table 254. Germany Nasal Decongestant Sales, by Type K Units (2015-2020)
  • Table 255. Germany Nasal Decongestant Sales, by Application K Units (2015-2020)
  • Table 256. Germany Nasal Decongestant Sales, by Form K Units (2015-2020)
  • Table 257. Germany Nasal Decongestant Sales, by Distribution Channel K Units (2015-2020)
  • Table 258. Germany Nasal Decongestant Sales, by End-user K Units (2015-2020)
  • Table 259. France Nasal Decongestant Sales, by Type K Units (2015-2020)
  • Table 260. France Nasal Decongestant Sales, by Application K Units (2015-2020)
  • Table 261. France Nasal Decongestant Sales, by Form K Units (2015-2020)
  • Table 262. France Nasal Decongestant Sales, by Distribution Channel K Units (2015-2020)
  • Table 263. France Nasal Decongestant Sales, by End-user K Units (2015-2020)
  • Table 264. Italy Nasal Decongestant Sales, by Type K Units (2015-2020)
  • Table 265. Italy Nasal Decongestant Sales, by Application K Units (2015-2020)
  • Table 266. Italy Nasal Decongestant Sales, by Form K Units (2015-2020)
  • Table 267. Italy Nasal Decongestant Sales, by Distribution Channel K Units (2015-2020)
  • Table 268. Italy Nasal Decongestant Sales, by End-user K Units (2015-2020)
  • Table 269. United Kingdom Nasal Decongestant Sales, by Type K Units (2015-2020)
  • Table 270. United Kingdom Nasal Decongestant Sales, by Application K Units (2015-2020)
  • Table 271. United Kingdom Nasal Decongestant Sales, by Form K Units (2015-2020)
  • Table 272. United Kingdom Nasal Decongestant Sales, by Distribution Channel K Units (2015-2020)
  • Table 273. United Kingdom Nasal Decongestant Sales, by End-user K Units (2015-2020)
  • Table 274. Netherlands Nasal Decongestant Sales, by Type K Units (2015-2020)
  • Table 275. Netherlands Nasal Decongestant Sales, by Application K Units (2015-2020)
  • Table 276. Netherlands Nasal Decongestant Sales, by Form K Units (2015-2020)
  • Table 277. Netherlands Nasal Decongestant Sales, by Distribution Channel K Units (2015-2020)
  • Table 278. Netherlands Nasal Decongestant Sales, by End-user K Units (2015-2020)
  • Table 279. Rest of Europe Nasal Decongestant Sales, by Type K Units (2015-2020)
  • Table 280. Rest of Europe Nasal Decongestant Sales, by Application K Units (2015-2020)
  • Table 281. Rest of Europe Nasal Decongestant Sales, by Form K Units (2015-2020)
  • Table 282. Rest of Europe Nasal Decongestant Sales, by Distribution Channel K Units (2015-2020)
  • Table 283. Rest of Europe Nasal Decongestant Sales, by End-user K Units (2015-2020)
  • Table 284. MEA Nasal Decongestant Sales, by Country K Units (2015-2020)
  • Table 285. MEA Nasal Decongestant Sales, by Type K Units (2015-2020)
  • Table 286. MEA Nasal Decongestant Sales, by Application K Units (2015-2020)
  • Table 287. MEA Nasal Decongestant Sales, by Form K Units (2015-2020)
  • Table 288. MEA Nasal Decongestant Sales, by Distribution Channel K Units (2015-2020)
  • Table 289. MEA Nasal Decongestant Sales, by End-user K Units (2015-2020)
  • Table 290. Middle East Nasal Decongestant Sales, by Type K Units (2015-2020)
  • Table 291. Middle East Nasal Decongestant Sales, by Application K Units (2015-2020)
  • Table 292. Middle East Nasal Decongestant Sales, by Form K Units (2015-2020)
  • Table 293. Middle East Nasal Decongestant Sales, by Distribution Channel K Units (2015-2020)
  • Table 294. Middle East Nasal Decongestant Sales, by End-user K Units (2015-2020)
  • Table 295. Africa Nasal Decongestant Sales, by Type K Units (2015-2020)
  • Table 296. Africa Nasal Decongestant Sales, by Application K Units (2015-2020)
  • Table 297. Africa Nasal Decongestant Sales, by Form K Units (2015-2020)
  • Table 298. Africa Nasal Decongestant Sales, by Distribution Channel K Units (2015-2020)
  • Table 299. Africa Nasal Decongestant Sales, by End-user K Units (2015-2020)
  • Table 300. North America Nasal Decongestant Sales, by Country K Units (2015-2020)
  • Table 301. North America Nasal Decongestant Sales, by Type K Units (2015-2020)
  • Table 302. North America Nasal Decongestant Sales, by Application K Units (2015-2020)
  • Table 303. North America Nasal Decongestant Sales, by Form K Units (2015-2020)
  • Table 304. North America Nasal Decongestant Sales, by Distribution Channel K Units (2015-2020)
  • Table 305. North America Nasal Decongestant Sales, by End-user K Units (2015-2020)
  • Table 306. United States Nasal Decongestant Sales, by Type K Units (2015-2020)
  • Table 307. United States Nasal Decongestant Sales, by Application K Units (2015-2020)
  • Table 308. United States Nasal Decongestant Sales, by Form K Units (2015-2020)
  • Table 309. United States Nasal Decongestant Sales, by Distribution Channel K Units (2015-2020)
  • Table 310. United States Nasal Decongestant Sales, by End-user K Units (2015-2020)
  • Table 311. Canada Nasal Decongestant Sales, by Type K Units (2015-2020)
  • Table 312. Canada Nasal Decongestant Sales, by Application K Units (2015-2020)
  • Table 313. Canada Nasal Decongestant Sales, by Form K Units (2015-2020)
  • Table 314. Canada Nasal Decongestant Sales, by Distribution Channel K Units (2015-2020)
  • Table 315. Canada Nasal Decongestant Sales, by End-user K Units (2015-2020)
  • Table 316. Mexico Nasal Decongestant Sales, by Type K Units (2015-2020)
  • Table 317. Mexico Nasal Decongestant Sales, by Application K Units (2015-2020)
  • Table 318. Mexico Nasal Decongestant Sales, by Form K Units (2015-2020)
  • Table 319. Mexico Nasal Decongestant Sales, by Distribution Channel K Units (2015-2020)
  • Table 320. Mexico Nasal Decongestant Sales, by End-user K Units (2015-2020)
  • Table 321. Nasal Decongestant: by Type(USD/Units)
  • Table 322. Company Basic Information, Sales Area and Its Competitors
  • Table 323. Company Basic Information, Sales Area and Its Competitors
  • Table 324. Company Basic Information, Sales Area and Its Competitors
  • Table 325. Company Basic Information, Sales Area and Its Competitors
  • Table 326. Company Basic Information, Sales Area and Its Competitors
  • Table 327. Company Basic Information, Sales Area and Its Competitors
  • Table 328. Company Basic Information, Sales Area and Its Competitors
  • Table 329. Company Basic Information, Sales Area and Its Competitors
  • Table 330. Company Basic Information, Sales Area and Its Competitors
  • Table 331. Company Basic Information, Sales Area and Its Competitors
  • Table 332. Nasal Decongestant: by Type(USD Million)
  • Table 333. Nasal Decongestant Phenylephrine , by Region USD Million (2021-2026)
  • Table 334. Nasal Decongestant Pseudoephedrine , by Region USD Million (2021-2026)
  • Table 335. Nasal Decongestant Intranasal Decongestants , by Region USD Million (2021-2026)
  • Table 336. Nasal Decongestant Intranasal Corticosteroids , by Region USD Million (2021-2026)
  • Table 337. Nasal Decongestant Antihistamines , by Region USD Million (2021-2026)
  • Table 338. Nasal Decongestant: by Application(USD Million)
  • Table 339. Nasal Decongestant Sinusitis , by Region USD Million (2021-2026)
  • Table 340. Nasal Decongestant Cold , by Region USD Million (2021-2026)
  • Table 341. Nasal Decongestant Rhinitis , by Region USD Million (2021-2026)
  • Table 342. Nasal Decongestant Nasal Allergies , by Region USD Million (2021-2026)
  • Table 343. Nasal Decongestant: by Form(USD Million)
  • Table 344. Nasal Decongestant Nasal Strips , by Region USD Million (2021-2026)
  • Table 345. Nasal Decongestant Tablet , by Region USD Million (2021-2026)
  • Table 346. Nasal Decongestant Spray , by Region USD Million (2021-2026)
  • Table 347. Nasal Decongestant Capsule , by Region USD Million (2021-2026)
  • Table 348. Nasal Decongestant: by Distribution Channel(USD Million)
  • Table 349. Nasal Decongestant Hospital Pharmacies , by Region USD Million (2021-2026)
  • Table 350. Nasal Decongestant Retail Pharmacies , by Region USD Million (2021-2026)
  • Table 351. Nasal Decongestant Online , by Region USD Million (2021-2026)
  • Table 352. Nasal Decongestant Others , by Region USD Million (2021-2026)
  • Table 353. Nasal Decongestant: by End-user(USD Million)
  • Table 354. Nasal Decongestant Hospitals , by Region USD Million (2021-2026)
  • Table 355. Nasal Decongestant Clinics , by Region USD Million (2021-2026)
  • Table 356. Nasal Decongestant Others , by Region USD Million (2021-2026)
  • Table 357. South America Nasal Decongestant, by Country USD Million (2021-2026)
  • Table 358. South America Nasal Decongestant, by Type USD Million (2021-2026)
  • Table 359. South America Nasal Decongestant, by Application USD Million (2021-2026)
  • Table 360. South America Nasal Decongestant, by Form USD Million (2021-2026)
  • Table 361. South America Nasal Decongestant, by Distribution Channel USD Million (2021-2026)
  • Table 362. South America Nasal Decongestant, by End-user USD Million (2021-2026)
  • Table 363. Brazil Nasal Decongestant, by Type USD Million (2021-2026)
  • Table 364. Brazil Nasal Decongestant, by Application USD Million (2021-2026)
  • Table 365. Brazil Nasal Decongestant, by Form USD Million (2021-2026)
  • Table 366. Brazil Nasal Decongestant, by Distribution Channel USD Million (2021-2026)
  • Table 367. Brazil Nasal Decongestant, by End-user USD Million (2021-2026)
  • Table 368. Argentina Nasal Decongestant, by Type USD Million (2021-2026)
  • Table 369. Argentina Nasal Decongestant, by Application USD Million (2021-2026)
  • Table 370. Argentina Nasal Decongestant, by Form USD Million (2021-2026)
  • Table 371. Argentina Nasal Decongestant, by Distribution Channel USD Million (2021-2026)
  • Table 372. Argentina Nasal Decongestant, by End-user USD Million (2021-2026)
  • Table 373. Rest of South America Nasal Decongestant, by Type USD Million (2021-2026)
  • Table 374. Rest of South America Nasal Decongestant, by Application USD Million (2021-2026)
  • Table 375. Rest of South America Nasal Decongestant, by Form USD Million (2021-2026)
  • Table 376. Rest of South America Nasal Decongestant, by Distribution Channel USD Million (2021-2026)
  • Table 377. Rest of South America Nasal Decongestant, by End-user USD Million (2021-2026)
  • Table 378. Asia Pacific Nasal Decongestant, by Country USD Million (2021-2026)
  • Table 379. Asia Pacific Nasal Decongestant, by Type USD Million (2021-2026)
  • Table 380. Asia Pacific Nasal Decongestant, by Application USD Million (2021-2026)
  • Table 381. Asia Pacific Nasal Decongestant, by Form USD Million (2021-2026)
  • Table 382. Asia Pacific Nasal Decongestant, by Distribution Channel USD Million (2021-2026)
  • Table 383. Asia Pacific Nasal Decongestant, by End-user USD Million (2021-2026)
  • Table 384. China Nasal Decongestant, by Type USD Million (2021-2026)
  • Table 385. China Nasal Decongestant, by Application USD Million (2021-2026)
  • Table 386. China Nasal Decongestant, by Form USD Million (2021-2026)
  • Table 387. China Nasal Decongestant, by Distribution Channel USD Million (2021-2026)
  • Table 388. China Nasal Decongestant, by End-user USD Million (2021-2026)
  • Table 389. Japan Nasal Decongestant, by Type USD Million (2021-2026)
  • Table 390. Japan Nasal Decongestant, by Application USD Million (2021-2026)
  • Table 391. Japan Nasal Decongestant, by Form USD Million (2021-2026)
  • Table 392. Japan Nasal Decongestant, by Distribution Channel USD Million (2021-2026)
  • Table 393. Japan Nasal Decongestant, by End-user USD Million (2021-2026)
  • Table 394. India Nasal Decongestant, by Type USD Million (2021-2026)
  • Table 395. India Nasal Decongestant, by Application USD Million (2021-2026)
  • Table 396. India Nasal Decongestant, by Form USD Million (2021-2026)
  • Table 397. India Nasal Decongestant, by Distribution Channel USD Million (2021-2026)
  • Table 398. India Nasal Decongestant, by End-user USD Million (2021-2026)
  • Table 399. South Korea Nasal Decongestant, by Type USD Million (2021-2026)
  • Table 400. South Korea Nasal Decongestant, by Application USD Million (2021-2026)
  • Table 401. South Korea Nasal Decongestant, by Form USD Million (2021-2026)
  • Table 402. South Korea Nasal Decongestant, by Distribution Channel USD Million (2021-2026)
  • Table 403. South Korea Nasal Decongestant, by End-user USD Million (2021-2026)
  • Table 404. Taiwan Nasal Decongestant, by Type USD Million (2021-2026)
  • Table 405. Taiwan Nasal Decongestant, by Application USD Million (2021-2026)
  • Table 406. Taiwan Nasal Decongestant, by Form USD Million (2021-2026)
  • Table 407. Taiwan Nasal Decongestant, by Distribution Channel USD Million (2021-2026)
  • Table 408. Taiwan Nasal Decongestant, by End-user USD Million (2021-2026)
  • Table 409. Australia Nasal Decongestant, by Type USD Million (2021-2026)
  • Table 410. Australia Nasal Decongestant, by Application USD Million (2021-2026)
  • Table 411. Australia Nasal Decongestant, by Form USD Million (2021-2026)
  • Table 412. Australia Nasal Decongestant, by Distribution Channel USD Million (2021-2026)
  • Table 413. Australia Nasal Decongestant, by End-user USD Million (2021-2026)
  • Table 414. Rest of Asia-Pacific Nasal Decongestant, by Type USD Million (2021-2026)
  • Table 415. Rest of Asia-Pacific Nasal Decongestant, by Application USD Million (2021-2026)
  • Table 416. Rest of Asia-Pacific Nasal Decongestant, by Form USD Million (2021-2026)
  • Table 417. Rest of Asia-Pacific Nasal Decongestant, by Distribution Channel USD Million (2021-2026)
  • Table 418. Rest of Asia-Pacific Nasal Decongestant, by End-user USD Million (2021-2026)
  • Table 419. Europe Nasal Decongestant, by Country USD Million (2021-2026)
  • Table 420. Europe Nasal Decongestant, by Type USD Million (2021-2026)
  • Table 421. Europe Nasal Decongestant, by Application USD Million (2021-2026)
  • Table 422. Europe Nasal Decongestant, by Form USD Million (2021-2026)
  • Table 423. Europe Nasal Decongestant, by Distribution Channel USD Million (2021-2026)
  • Table 424. Europe Nasal Decongestant, by End-user USD Million (2021-2026)
  • Table 425. Germany Nasal Decongestant, by Type USD Million (2021-2026)
  • Table 426. Germany Nasal Decongestant, by Application USD Million (2021-2026)
  • Table 427. Germany Nasal Decongestant, by Form USD Million (2021-2026)
  • Table 428. Germany Nasal Decongestant, by Distribution Channel USD Million (2021-2026)
  • Table 429. Germany Nasal Decongestant, by End-user USD Million (2021-2026)
  • Table 430. France Nasal Decongestant, by Type USD Million (2021-2026)
  • Table 431. France Nasal Decongestant, by Application USD Million (2021-2026)
  • Table 432. France Nasal Decongestant, by Form USD Million (2021-2026)
  • Table 433. France Nasal Decongestant, by Distribution Channel USD Million (2021-2026)
  • Table 434. France Nasal Decongestant, by End-user USD Million (2021-2026)
  • Table 435. Italy Nasal Decongestant, by Type USD Million (2021-2026)
  • Table 436. Italy Nasal Decongestant, by Application USD Million (2021-2026)
  • Table 437. Italy Nasal Decongestant, by Form USD Million (2021-2026)
  • Table 438. Italy Nasal Decongestant, by Distribution Channel USD Million (2021-2026)
  • Table 439. Italy Nasal Decongestant, by End-user USD Million (2021-2026)
  • Table 440. United Kingdom Nasal Decongestant, by Type USD Million (2021-2026)
  • Table 441. United Kingdom Nasal Decongestant, by Application USD Million (2021-2026)
  • Table 442. United Kingdom Nasal Decongestant, by Form USD Million (2021-2026)
  • Table 443. United Kingdom Nasal Decongestant, by Distribution Channel USD Million (2021-2026)
  • Table 444. United Kingdom Nasal Decongestant, by End-user USD Million (2021-2026)
  • Table 445. Netherlands Nasal Decongestant, by Type USD Million (2021-2026)
  • Table 446. Netherlands Nasal Decongestant, by Application USD Million (2021-2026)
  • Table 447. Netherlands Nasal Decongestant, by Form USD Million (2021-2026)
  • Table 448. Netherlands Nasal Decongestant, by Distribution Channel USD Million (2021-2026)
  • Table 449. Netherlands Nasal Decongestant, by End-user USD Million (2021-2026)
  • Table 450. Rest of Europe Nasal Decongestant, by Type USD Million (2021-2026)
  • Table 451. Rest of Europe Nasal Decongestant, by Application USD Million (2021-2026)
  • Table 452. Rest of Europe Nasal Decongestant, by Form USD Million (2021-2026)
  • Table 453. Rest of Europe Nasal Decongestant, by Distribution Channel USD Million (2021-2026)
  • Table 454. Rest of Europe Nasal Decongestant, by End-user USD Million (2021-2026)
  • Table 455. MEA Nasal Decongestant, by Country USD Million (2021-2026)
  • Table 456. MEA Nasal Decongestant, by Type USD Million (2021-2026)
  • Table 457. MEA Nasal Decongestant, by Application USD Million (2021-2026)
  • Table 458. MEA Nasal Decongestant, by Form USD Million (2021-2026)
  • Table 459. MEA Nasal Decongestant, by Distribution Channel USD Million (2021-2026)
  • Table 460. MEA Nasal Decongestant, by End-user USD Million (2021-2026)
  • Table 461. Middle East Nasal Decongestant, by Type USD Million (2021-2026)
  • Table 462. Middle East Nasal Decongestant, by Application USD Million (2021-2026)
  • Table 463. Middle East Nasal Decongestant, by Form USD Million (2021-2026)
  • Table 464. Middle East Nasal Decongestant, by Distribution Channel USD Million (2021-2026)
  • Table 465. Middle East Nasal Decongestant, by End-user USD Million (2021-2026)
  • Table 466. Africa Nasal Decongestant, by Type USD Million (2021-2026)
  • Table 467. Africa Nasal Decongestant, by Application USD Million (2021-2026)
  • Table 468. Africa Nasal Decongestant, by Form USD Million (2021-2026)
  • Table 469. Africa Nasal Decongestant, by Distribution Channel USD Million (2021-2026)
  • Table 470. Africa Nasal Decongestant, by End-user USD Million (2021-2026)
  • Table 471. North America Nasal Decongestant, by Country USD Million (2021-2026)
  • Table 472. North America Nasal Decongestant, by Type USD Million (2021-2026)
  • Table 473. North America Nasal Decongestant, by Application USD Million (2021-2026)
  • Table 474. North America Nasal Decongestant, by Form USD Million (2021-2026)
  • Table 475. North America Nasal Decongestant, by Distribution Channel USD Million (2021-2026)
  • Table 476. North America Nasal Decongestant, by End-user USD Million (2021-2026)
  • Table 477. United States Nasal Decongestant, by Type USD Million (2021-2026)
  • Table 478. United States Nasal Decongestant, by Application USD Million (2021-2026)
  • Table 479. United States Nasal Decongestant, by Form USD Million (2021-2026)
  • Table 480. United States Nasal Decongestant, by Distribution Channel USD Million (2021-2026)
  • Table 481. United States Nasal Decongestant, by End-user USD Million (2021-2026)
  • Table 482. Canada Nasal Decongestant, by Type USD Million (2021-2026)
  • Table 483. Canada Nasal Decongestant, by Application USD Million (2021-2026)
  • Table 484. Canada Nasal Decongestant, by Form USD Million (2021-2026)
  • Table 485. Canada Nasal Decongestant, by Distribution Channel USD Million (2021-2026)
  • Table 486. Canada Nasal Decongestant, by End-user USD Million (2021-2026)
  • Table 487. Mexico Nasal Decongestant, by Type USD Million (2021-2026)
  • Table 488. Mexico Nasal Decongestant, by Application USD Million (2021-2026)
  • Table 489. Mexico Nasal Decongestant, by Form USD Million (2021-2026)
  • Table 490. Mexico Nasal Decongestant, by Distribution Channel USD Million (2021-2026)
  • Table 491. Mexico Nasal Decongestant, by End-user USD Million (2021-2026)
  • Table 492. Nasal Decongestant Sales: by Type(K Units)
  • Table 493. Nasal Decongestant Sales Phenylephrine , by Region K Units (2021-2026)
  • Table 494. Nasal Decongestant Sales Pseudoephedrine , by Region K Units (2021-2026)
  • Table 495. Nasal Decongestant Sales Intranasal Decongestants , by Region K Units (2021-2026)
  • Table 496. Nasal Decongestant Sales Intranasal Corticosteroids , by Region K Units (2021-2026)
  • Table 497. Nasal Decongestant Sales Antihistamines , by Region K Units (2021-2026)
  • Table 498. Nasal Decongestant Sales: by Application(K Units)
  • Table 499. Nasal Decongestant Sales Sinusitis , by Region K Units (2021-2026)
  • Table 500. Nasal Decongestant Sales Cold , by Region K Units (2021-2026)
  • Table 501. Nasal Decongestant Sales Rhinitis , by Region K Units (2021-2026)
  • Table 502. Nasal Decongestant Sales Nasal Allergies , by Region K Units (2021-2026)
  • Table 503. Nasal Decongestant Sales: by Form(K Units)
  • Table 504. Nasal Decongestant Sales Nasal Strips , by Region K Units (2021-2026)
  • Table 505. Nasal Decongestant Sales Tablet , by Region K Units (2021-2026)
  • Table 506. Nasal Decongestant Sales Spray , by Region K Units (2021-2026)
  • Table 507. Nasal Decongestant Sales Capsule , by Region K Units (2021-2026)
  • Table 508. Nasal Decongestant Sales: by Distribution Channel(K Units)
  • Table 509. Nasal Decongestant Sales Hospital Pharmacies , by Region K Units (2021-2026)
  • Table 510. Nasal Decongestant Sales Retail Pharmacies , by Region K Units (2021-2026)
  • Table 511. Nasal Decongestant Sales Online , by Region K Units (2021-2026)
  • Table 512. Nasal Decongestant Sales Others , by Region K Units (2021-2026)
  • Table 513. Nasal Decongestant Sales: by End-user(K Units)
  • Table 514. Nasal Decongestant Sales Hospitals , by Region K Units (2021-2026)
  • Table 515. Nasal Decongestant Sales Clinics , by Region K Units (2021-2026)
  • Table 516. Nasal Decongestant Sales Others , by Region K Units (2021-2026)
  • Table 517. South America Nasal Decongestant Sales, by Country K Units (2021-2026)
  • Table 518. South America Nasal Decongestant Sales, by Type K Units (2021-2026)
  • Table 519. South America Nasal Decongestant Sales, by Application K Units (2021-2026)
  • Table 520. South America Nasal Decongestant Sales, by Form K Units (2021-2026)
  • Table 521. South America Nasal Decongestant Sales, by Distribution Channel K Units (2021-2026)
  • Table 522. South America Nasal Decongestant Sales, by End-user K Units (2021-2026)
  • Table 523. Brazil Nasal Decongestant Sales, by Type K Units (2021-2026)
  • Table 524. Brazil Nasal Decongestant Sales, by Application K Units (2021-2026)
  • Table 525. Brazil Nasal Decongestant Sales, by Form K Units (2021-2026)
  • Table 526. Brazil Nasal Decongestant Sales, by Distribution Channel K Units (2021-2026)
  • Table 527. Brazil Nasal Decongestant Sales, by End-user K Units (2021-2026)
  • Table 528. Argentina Nasal Decongestant Sales, by Type K Units (2021-2026)
  • Table 529. Argentina Nasal Decongestant Sales, by Application K Units (2021-2026)
  • Table 530. Argentina Nasal Decongestant Sales, by Form K Units (2021-2026)
  • Table 531. Argentina Nasal Decongestant Sales, by Distribution Channel K Units (2021-2026)
  • Table 532. Argentina Nasal Decongestant Sales, by End-user K Units (2021-2026)
  • Table 533. Rest of South America Nasal Decongestant Sales, by Type K Units (2021-2026)
  • Table 534. Rest of South America Nasal Decongestant Sales, by Application K Units (2021-2026)
  • Table 535. Rest of South America Nasal Decongestant Sales, by Form K Units (2021-2026)
  • Table 536. Rest of South America Nasal Decongestant Sales, by Distribution Channel K Units (2021-2026)
  • Table 537. Rest of South America Nasal Decongestant Sales, by End-user K Units (2021-2026)
  • Table 538. Asia Pacific Nasal Decongestant Sales, by Country K Units (2021-2026)
  • Table 539. Asia Pacific Nasal Decongestant Sales, by Type K Units (2021-2026)
  • Table 540. Asia Pacific Nasal Decongestant Sales, by Application K Units (2021-2026)
  • Table 541. Asia Pacific Nasal Decongestant Sales, by Form K Units (2021-2026)
  • Table 542. Asia Pacific Nasal Decongestant Sales, by Distribution Channel K Units (2021-2026)
  • Table 543. Asia Pacific Nasal Decongestant Sales, by End-user K Units (2021-2026)
  • Table 544. China Nasal Decongestant Sales, by Type K Units (2021-2026)
  • Table 545. China Nasal Decongestant Sales, by Application K Units (2021-2026)
  • Table 546. China Nasal Decongestant Sales, by Form K Units (2021-2026)
  • Table 547. China Nasal Decongestant Sales, by Distribution Channel K Units (2021-2026)
  • Table 548. China Nasal Decongestant Sales, by End-user K Units (2021-2026)
  • Table 549. Japan Nasal Decongestant Sales, by Type K Units (2021-2026)
  • Table 550. Japan Nasal Decongestant Sales, by Application K Units (2021-2026)
  • Table 551. Japan Nasal Decongestant Sales, by Form K Units (2021-2026)
  • Table 552. Japan Nasal Decongestant Sales, by Distribution Channel K Units (2021-2026)
  • Table 553. Japan Nasal Decongestant Sales, by End-user K Units (2021-2026)
  • Table 554. India Nasal Decongestant Sales, by Type K Units (2021-2026)
  • Table 555. India Nasal Decongestant Sales, by Application K Units (2021-2026)
  • Table 556. India Nasal Decongestant Sales, by Form K Units (2021-2026)
  • Table 557. India Nasal Decongestant Sales, by Distribution Channel K Units (2021-2026)
  • Table 558. India Nasal Decongestant Sales, by End-user K Units (2021-2026)
  • Table 559. South Korea Nasal Decongestant Sales, by Type K Units (2021-2026)
  • Table 560. South Korea Nasal Decongestant Sales, by Application K Units (2021-2026)
  • Table 561. South Korea Nasal Decongestant Sales, by Form K Units (2021-2026)
  • Table 562. South Korea Nasal Decongestant Sales, by Distribution Channel K Units (2021-2026)
  • Table 563. South Korea Nasal Decongestant Sales, by End-user K Units (2021-2026)
  • Table 564. Taiwan Nasal Decongestant Sales, by Type K Units (2021-2026)
  • Table 565. Taiwan Nasal Decongestant Sales, by Application K Units (2021-2026)
  • Table 566. Taiwan Nasal Decongestant Sales, by Form K Units (2021-2026)
  • Table 567. Taiwan Nasal Decongestant Sales, by Distribution Channel K Units (2021-2026)
  • Table 568. Taiwan Nasal Decongestant Sales, by End-user K Units (2021-2026)
  • Table 569. Australia Nasal Decongestant Sales, by Type K Units (2021-2026)
  • Table 570. Australia Nasal Decongestant Sales, by Application K Units (2021-2026)
  • Table 571. Australia Nasal Decongestant Sales, by Form K Units (2021-2026)
  • Table 572. Australia Nasal Decongestant Sales, by Distribution Channel K Units (2021-2026)
  • Table 573. Australia Nasal Decongestant Sales, by End-user K Units (2021-2026)
  • Table 574. Rest of Asia-Pacific Nasal Decongestant Sales, by Type K Units (2021-2026)
  • Table 575. Rest of Asia-Pacific Nasal Decongestant Sales, by Application K Units (2021-2026)
  • Table 576. Rest of Asia-Pacific Nasal Decongestant Sales, by Form K Units (2021-2026)
  • Table 577. Rest of Asia-Pacific Nasal Decongestant Sales, by Distribution Channel K Units (2021-2026)
  • Table 578. Rest of Asia-Pacific Nasal Decongestant Sales, by End-user K Units (2021-2026)
  • Table 579. Europe Nasal Decongestant Sales, by Country K Units (2021-2026)
  • Table 580. Europe Nasal Decongestant Sales, by Type K Units (2021-2026)
  • Table 581. Europe Nasal Decongestant Sales, by Application K Units (2021-2026)
  • Table 582. Europe Nasal Decongestant Sales, by Form K Units (2021-2026)
  • Table 583. Europe Nasal Decongestant Sales, by Distribution Channel K Units (2021-2026)
  • Table 584. Europe Nasal Decongestant Sales, by End-user K Units (2021-2026)
  • Table 585. Germany Nasal Decongestant Sales, by Type K Units (2021-2026)
  • Table 586. Germany Nasal Decongestant Sales, by Application K Units (2021-2026)
  • Table 587. Germany Nasal Decongestant Sales, by Form K Units (2021-2026)
  • Table 588. Germany Nasal Decongestant Sales, by Distribution Channel K Units (2021-2026)
  • Table 589. Germany Nasal Decongestant Sales, by End-user K Units (2021-2026)
  • Table 590. France Nasal Decongestant Sales, by Type K Units (2021-2026)
  • Table 591. France Nasal Decongestant Sales, by Application K Units (2021-2026)
  • Table 592. France Nasal Decongestant Sales, by Form K Units (2021-2026)
  • Table 593. France Nasal Decongestant Sales, by Distribution Channel K Units (2021-2026)
  • Table 594. France Nasal Decongestant Sales, by End-user K Units (2021-2026)
  • Table 595. Italy Nasal Decongestant Sales, by Type K Units (2021-2026)
  • Table 596. Italy Nasal Decongestant Sales, by Application K Units (2021-2026)
  • Table 597. Italy Nasal Decongestant Sales, by Form K Units (2021-2026)
  • Table 598. Italy Nasal Decongestant Sales, by Distribution Channel K Units (2021-2026)
  • Table 599. Italy Nasal Decongestant Sales, by End-user K Units (2021-2026)
  • Table 600. United Kingdom Nasal Decongestant Sales, by Type K Units (2021-2026)
  • Table 601. United Kingdom Nasal Decongestant Sales, by Application K Units (2021-2026)
  • Table 602. United Kingdom Nasal Decongestant Sales, by Form K Units (2021-2026)
  • Table 603. United Kingdom Nasal Decongestant Sales, by Distribution Channel K Units (2021-2026)
  • Table 604. United Kingdom Nasal Decongestant Sales, by End-user K Units (2021-2026)
  • Table 605. Netherlands Nasal Decongestant Sales, by Type K Units (2021-2026)
  • Table 606. Netherlands Nasal Decongestant Sales, by Application K Units (2021-2026)
  • Table 607. Netherlands Nasal Decongestant Sales, by Form K Units (2021-2026)
  • Table 608. Netherlands Nasal Decongestant Sales, by Distribution Channel K Units (2021-2026)
  • Table 609. Netherlands Nasal Decongestant Sales, by End-user K Units (2021-2026)
  • Table 610. Rest of Europe Nasal Decongestant Sales, by Type K Units (2021-2026)
  • Table 611. Rest of Europe Nasal Decongestant Sales, by Application K Units (2021-2026)
  • Table 612. Rest of Europe Nasal Decongestant Sales, by Form K Units (2021-2026)
  • Table 613. Rest of Europe Nasal Decongestant Sales, by Distribution Channel K Units (2021-2026)
  • Table 614. Rest of Europe Nasal Decongestant Sales, by End-user K Units (2021-2026)
  • Table 615. MEA Nasal Decongestant Sales, by Country K Units (2021-2026)
  • Table 616. MEA Nasal Decongestant Sales, by Type K Units (2021-2026)
  • Table 617. MEA Nasal Decongestant Sales, by Application K Units (2021-2026)
  • Table 618. MEA Nasal Decongestant Sales, by Form K Units (2021-2026)
  • Table 619. MEA Nasal Decongestant Sales, by Distribution Channel K Units (2021-2026)
  • Table 620. MEA Nasal Decongestant Sales, by End-user K Units (2021-2026)
  • Table 621. Middle East Nasal Decongestant Sales, by Type K Units (2021-2026)
  • Table 622. Middle East Nasal Decongestant Sales, by Application K Units (2021-2026)
  • Table 623. Middle East Nasal Decongestant Sales, by Form K Units (2021-2026)
  • Table 624. Middle East Nasal Decongestant Sales, by Distribution Channel K Units (2021-2026)
  • Table 625. Middle East Nasal Decongestant Sales, by End-user K Units (2021-2026)
  • Table 626. Africa Nasal Decongestant Sales, by Type K Units (2021-2026)
  • Table 627. Africa Nasal Decongestant Sales, by Application K Units (2021-2026)
  • Table 628. Africa Nasal Decongestant Sales, by Form K Units (2021-2026)
  • Table 629. Africa Nasal Decongestant Sales, by Distribution Channel K Units (2021-2026)
  • Table 630. Africa Nasal Decongestant Sales, by End-user K Units (2021-2026)
  • Table 631. North America Nasal Decongestant Sales, by Country K Units (2021-2026)
  • Table 632. North America Nasal Decongestant Sales, by Type K Units (2021-2026)
  • Table 633. North America Nasal Decongestant Sales, by Application K Units (2021-2026)
  • Table 634. North America Nasal Decongestant Sales, by Form K Units (2021-2026)
  • Table 635. North America Nasal Decongestant Sales, by Distribution Channel K Units (2021-2026)
  • Table 636. North America Nasal Decongestant Sales, by End-user K Units (2021-2026)
  • Table 637. United States Nasal Decongestant Sales, by Type K Units (2021-2026)
  • Table 638. United States Nasal Decongestant Sales, by Application K Units (2021-2026)
  • Table 639. United States Nasal Decongestant Sales, by Form K Units (2021-2026)
  • Table 640. United States Nasal Decongestant Sales, by Distribution Channel K Units (2021-2026)
  • Table 641. United States Nasal Decongestant Sales, by End-user K Units (2021-2026)
  • Table 642. Canada Nasal Decongestant Sales, by Type K Units (2021-2026)
  • Table 643. Canada Nasal Decongestant Sales, by Application K Units (2021-2026)
  • Table 644. Canada Nasal Decongestant Sales, by Form K Units (2021-2026)
  • Table 645. Canada Nasal Decongestant Sales, by Distribution Channel K Units (2021-2026)
  • Table 646. Canada Nasal Decongestant Sales, by End-user K Units (2021-2026)
  • Table 647. Mexico Nasal Decongestant Sales, by Type K Units (2021-2026)
  • Table 648. Mexico Nasal Decongestant Sales, by Application K Units (2021-2026)
  • Table 649. Mexico Nasal Decongestant Sales, by Form K Units (2021-2026)
  • Table 650. Mexico Nasal Decongestant Sales, by Distribution Channel K Units (2021-2026)
  • Table 651. Mexico Nasal Decongestant Sales, by End-user K Units (2021-2026)
  • Table 652. Nasal Decongestant: by Type(USD/Units)
  • Table 653. Research Programs/Design for This Report
  • Table 654. Key Data Information from Secondary Sources
  • Table 655. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Nasal Decongestant: by Type USD Million (2015-2020)
  • Figure 5. Global Nasal Decongestant: by Application USD Million (2015-2020)
  • Figure 6. Global Nasal Decongestant: by Form USD Million (2015-2020)
  • Figure 7. Global Nasal Decongestant: by Distribution Channel USD Million (2015-2020)
  • Figure 8. Global Nasal Decongestant: by End-user USD Million (2015-2020)
  • Figure 9. South America Nasal Decongestant Share (%), by Country
  • Figure 10. Asia Pacific Nasal Decongestant Share (%), by Country
  • Figure 11. Europe Nasal Decongestant Share (%), by Country
  • Figure 12. MEA Nasal Decongestant Share (%), by Country
  • Figure 13. North America Nasal Decongestant Share (%), by Country
  • Figure 14. Global Nasal Decongestant: by Type K Units (2015-2020)
  • Figure 15. Global Nasal Decongestant: by Application K Units (2015-2020)
  • Figure 16. Global Nasal Decongestant: by Form K Units (2015-2020)
  • Figure 17. Global Nasal Decongestant: by Distribution Channel K Units (2015-2020)
  • Figure 18. Global Nasal Decongestant: by End-user K Units (2015-2020)
  • Figure 19. South America Nasal Decongestant Share (%), by Country
  • Figure 20. Asia Pacific Nasal Decongestant Share (%), by Country
  • Figure 21. Europe Nasal Decongestant Share (%), by Country
  • Figure 22. MEA Nasal Decongestant Share (%), by Country
  • Figure 23. North America Nasal Decongestant Share (%), by Country
  • Figure 24. Global Nasal Decongestant: by Type USD/Units (2015-2020)
  • Figure 25. Global Nasal Decongestant share by Players 2020 (%)
  • Figure 26. Global Nasal Decongestant share by Players (Top 3) 2020(%)
  • Figure 27. Global Nasal Decongestant share by Players (Top 5) 2020(%)
  • Figure 28. BCG Matrix for key Companies
  • Figure 29. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 30. Abbott Laboratories (United States) Revenue: by Geography 2020
  • Figure 31. GlaxoSmithKline plc (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 32. GlaxoSmithKline plc (United Kingdom) Revenue: by Geography 2020
  • Figure 33. Cipla Limited (India) Revenue, Net Income and Gross profit
  • Figure 34. Cipla Limited (India) Revenue: by Geography 2020
  • Figure 35. Bayer AG (Germany) Revenue, Net Income and Gross profit
  • Figure 36. Bayer AG (Germany) Revenue: by Geography 2020
  • Figure 37. Adapt Pharma (United States) Revenue, Net Income and Gross profit
  • Figure 38. Adapt Pharma (United States) Revenue: by Geography 2020
  • Figure 39. Cadila Healthcare (India) Revenue, Net Income and Gross profit
  • Figure 40. Cadila Healthcare (India) Revenue: by Geography 2020
  • Figure 41. Nidda Healthcare Holding GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 42. Nidda Healthcare Holding GmbH (Germany) Revenue: by Geography 2020
  • Figure 43. Procter and Gamble (United States) Revenue, Net Income and Gross profit
  • Figure 44. Procter and Gamble (United States) Revenue: by Geography 2020
  • Figure 45. Transo-Pharm Handels-GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 46. Transo-Pharm Handels-GmbH (Germany) Revenue: by Geography 2020
  • Figure 47. Sun Pharmaceutical Industries Ltd. (India) Revenue, Net Income and Gross profit
  • Figure 48. Sun Pharmaceutical Industries Ltd. (India) Revenue: by Geography 2020
  • Figure 49. Global Nasal Decongestant: by Type USD Million (2021-2026)
  • Figure 50. Global Nasal Decongestant: by Application USD Million (2021-2026)
  • Figure 51. Global Nasal Decongestant: by Form USD Million (2021-2026)
  • Figure 52. Global Nasal Decongestant: by Distribution Channel USD Million (2021-2026)
  • Figure 53. Global Nasal Decongestant: by End-user USD Million (2021-2026)
  • Figure 54. South America Nasal Decongestant Share (%), by Country
  • Figure 55. Asia Pacific Nasal Decongestant Share (%), by Country
  • Figure 56. Europe Nasal Decongestant Share (%), by Country
  • Figure 57. MEA Nasal Decongestant Share (%), by Country
  • Figure 58. North America Nasal Decongestant Share (%), by Country
  • Figure 59. Global Nasal Decongestant: by Type K Units (2021-2026)
  • Figure 60. Global Nasal Decongestant: by Application K Units (2021-2026)
  • Figure 61. Global Nasal Decongestant: by Form K Units (2021-2026)
  • Figure 62. Global Nasal Decongestant: by Distribution Channel K Units (2021-2026)
  • Figure 63. Global Nasal Decongestant: by End-user K Units (2021-2026)
  • Figure 64. South America Nasal Decongestant Share (%), by Country
  • Figure 65. Asia Pacific Nasal Decongestant Share (%), by Country
  • Figure 66. Europe Nasal Decongestant Share (%), by Country
  • Figure 67. MEA Nasal Decongestant Share (%), by Country
  • Figure 68. North America Nasal Decongestant Share (%), by Country
  • Figure 69. Global Nasal Decongestant: by Type USD/Units (2021-2026)
List of companies from research coverage that are profiled in the study
  • Abbott Laboratories (United States)
  • GlaxoSmithKline plc (United Kingdom)
  • Cipla Limited (India)
  • Bayer AG (Germany)
  • Adapt Pharma (United States)
  • Cadila Healthcare (India)
  • Nidda Healthcare Holding GmbH (Germany)
  • Procter and Gamble (United States)
  • Transo-Pharm Handels-GmbH (Germany)
  • Sun Pharmaceutical Industries Ltd. (India)
Additional players considered in the study are as follows:
Taj Pharmaceuticals (India) , McNeil Consumer Healthcare (United States)
Select User Access Type

Key Highlights of Report


Feb 2021 246 Pages 66 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Nasal Decongestant Market Quantitative research analysis
Global Nasal Decongestant Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

"Increased Prevalence of Allergies among People " is seen as one of major growth factors of Nasal Decongestant Market in years to come.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.

Know More About Global Nasal Decongestant Market Report?

Have a Query? Click Here

Other Related Reports

Zaleplon Comprehensive Study by Type (5mg, 10mg, 20 mg), Drug type (Prescripted, OTC), Dosage form (Oral, Intranasal), End User (Hospitals, Clinics, Others) Players and Region - Global Market Outlook...
$ 3500
Butorphanol Comprehensive Study by Type (Spray, Injection, Tablet), Application (Human, Veterinary), Drug (Prescripted, OTC) Players and Region - Global Market Outlook to 2026
$ 3500
Head Lice Drug Comprehensive Study by Type (OTC Medication (Permethrin, Pyrethrin, Other), Prescription Medication (Ivermectin, Spinosad, Malathion, Other)), Application (Children, Adult), Form (Loti...
$ 3650
Swallowing Disorder Products Comprehensive Study by Type (Food Products, Powder Thickener, Ready-to-drink thickened beverages, Oral nutritional supplements, Feeding Aids & Tubes), Sales Distribution ...
$ 3450
Panacis Quinquefolis Comprehensive Study by Application (Anxiety, Mental Disorder, Menopause, Type 2 Diabetes, Heart Disease, Cancer, Alzheimer), Form (Fragment, Capsule, Powder, Others), Parts Used ...
$ 3500
Ossotide Tablets Comprehensive Study by Application (Fractures, Osteoarthritis, Rheumatism, Rheumatoid Arthritis), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online) Players and Re...
$ 3500